Justine Ross

5PUBLICATIONS
14CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
Incidence of hospital-onset bacteremia and fungemia in solid organ malignancy, hematologic malignancy, and hematopoietic cell transplant patients.

Sara Kurd-Misto, Justine Ross, Samantha Bastow

|Aug 13, 2024
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.

Justine Abella Ross, Brian Lee, Huiyan Ma

|Jan 13, 2022
Letermovir and maribavir for pan-resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy.

Jana K Dickter, Justine A Ross, Jasmine M Zain

|Dec 07, 2021
Infectious complications of immune checkpoint inhibitors in solid organ malignancies.

Justine Abella Ross, Kellie Komoda, Sumanta Pal

|Jun 10, 2021
Ibalizumab-uiyk as a bridge therapy for a patient with drug-resistant HIV-1 infection receiving chemotherapy: A case report.

Jana K Dickter, Abigail L Martin, Stephanie Ho

Pageof 1

Frequent Collaborators

4 joint publications

Jana K Dickter

2 joint publications

Sanjeet Singh Dadwal

1 joint publications

Sumanta Pal

1 joint publications

Ravi Salgia